Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting
Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cel...
Guardado en:
Autores principales: | Vincenzo De Giorgi, Federica Scarfì, Luciana Trane, Flavia Silvestri, Federico Venturi, Biancamaria Zuccaro, Giuseppe Spinelli, Silvia Scoccianti, Francesco De Rosa, Emi Dika, Caterina Longo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab09db568bb044a0bb97d0cb8ac68486 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis
por: Ralf Gutzmer, et al.
Publicado: (2021) -
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
por: Sabino Strippoli, et al.
Publicado: (2021) -
Lichen Planus Mimicking Atypical Melanocytic Lesion in a Man With Dark Skin
por: Federica Scarfi, et al.
Publicado: (2020) -
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
por: Anastasia V. Ignatova
Publicado: (2021) -
Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
por: Jacob D. Siegel, MD, et al.
Publicado: (2021)